Revive Therapeutics Ltd (RVVTF)

[its only money]

A new study published in Nature Communications aims to shed at least some light on common long COVID symptoms. The study analyzed data from 154,068 people in the Veterans Health Administration system who had COVID-19 and compared it to about 5.6 million people with similar characteristics who did not have the virus. The researchers discovered that people who had COVID-19 were 36% more likely to develop long-term gastrointestinal issues they didn’t have before they got the virus. More than 9,600 of those patients who had COVID-19 developed issues with their digestion, intestines, pancreas, or liver.

Lets hope Bucillamine can be a great treatment for some of the issues with long covid.